Pre-treatment with a P2Y12 antagonist before PCI in STEMI: why should we wait?-Reference-Cited by-同舟云学术

Pre-treatment with a P2Y12 antagonist before PCI in STEMI: why should we wait?

Published:2019-03-09 Issue:15 Volume:40 Page:1211-1213
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Abtan Jeremie¹²,Steg P Gabriel¹²³

Affiliation:

1. DHU (Département Hospitalo-Universitaire)-FIRE (Fibrosis, Inflammation, REmodelling), Hôpital Bichat, AP-HP (Assistance Publique-Hôpitaux de Paris), Université Paris-Diderot, Sorbonne-Paris Cité, Paris France

2. FACT (French Alliance for Cardiovascular clinical Trials), an F-CRIN network, INSERM U-1148, Paris, France

3. NLHI, ICMS, Royal Brompton Hospital, Imperial College, London, UK

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/40/15/1211/28374075/ehz058.pdf

Reference20 articles.

1. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study;Mehta;Lancet,2001

2. Pretreatment with antiplatelet drugs in invasively managed patients with coronary artery disease in the contemporary era: review of the evidence and practice guidelines;Capodanno;Circ Cardiovasc Interv,2015

3. Association of clopidogrel pretreatment with mortality, cardiovascular events, and major bleeding among patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis;Bellemain-Appaix;JAMA,2012

4. Reappraisal of thienopyridine pretreatment in patients with non-ST elevation acute coronary syndrome: a systematic review and meta-analysis;Bellemain-Appaix;BMJ,2014

5. Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes;Montalescot;N Engl J Med,2013

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and Safety of P2Y12 Inhibitor Pretreatment for Primary PCI in STEMI: Systematic Review and Meta-analysis;Journal of Cardiovascular Pharmacology;2023-10

2. Pretreatment with P2Y12 inhibitors in ST‐elevation myocardial infarction: A systematic review and meta‐analysis;Catheterization and Cardiovascular Interventions;2023-06-23

3. Effectiveness and safety of P2Y12 inhibitor pretreatment for primary PCI in STEMI: Systematic review and meta-analysis;2023-01-16

4. Integrated Multichip Analysis and WGCNA Identify Potential Diagnostic Markers in the Pathogenesis of ST-Elevation Myocardial Infarction;Contrast Media & Molecular Imaging;2022-04-07

5. Pretreatment with P2Y12 inhibitors in ST-elevation myocardial infarction: Should we keep doing it?;Revista Portuguesa de Cardiologia;2020-10